U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H29O2.Na
Molecular Weight 300.4114
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 3
Charge 0

SHOW SMILES / InChI
Structure of SODIUM .GAMMA.-LINOLENATE

SMILES

[Na+].CCCCC\C=C/C\C=C/C\C=C/CCCCC([O-])=O

InChI

InChIKey=MQLYJTAVSNRQGM-HPFCUAHCSA-M
InChI=1S/C18H30O2.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20);/q;+1/p-1/b7-6-,10-9-,13-12-;

HIDE SMILES / InChI

Molecular Formula C18H29O2
Molecular Weight 277.4217
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 3
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Gamolenic acid also known as gamma-lonolenic acid is a natural component of Oenothera biennis L. (Evening Primrose). Gamolenic acid was used for the treatment of breast painand atopic dermatitis in Europe, although now the drug is withdrawn from the market (there is no safety issue associated with the withdrawal of the licences). The mechanism of action of gamolenic acid is connected with its interaction with prostanoid pathway.

Originator

Curator's Comment: The substance was isolated by Heiduschka A. and Luft K. in 1919 from seed oil of Oenothera biennis and was synthesized by Osbond J.M. in 1961.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
EFAMAST

Approved Use

Unknown
Primary
EPOGAM

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
gamma-Carboxyglutamate excretion and warfarin therapy.
1979 May
Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1?
1989 Sep
Plasma and tissue levels of lipids, fatty acids and plasma carnitine in neonates receiving a new fat emulsion.
1997 Jun
Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids.
1997 Oct
Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet.
1997 Sep
Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
1999 Jul 14
Identification of the major intestinal fatty acid transport protein.
1999 Sep
The influence of polyunsaturated fatty acids on probiotic growth and adhesion.
2001 Jan 15
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.
2005 Jan
Induction of apoptosis in K562/ADM cells by gamma-linolenic acid involves lipid peroxidation and activation of caspase-3.
2006 Aug 25
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids.
2007 Jan 15
Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
2008 Apr
Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms.
2010 Aug
Antineoplastic effects of gamma linolenic Acid on hepatocellular carcinoma cell lines.
2010 Jul
JNK implication in adipocyte-like cell death induced by chemotherapeutic drug cisplatin.
2015 Feb
Patents

Sample Use Guides

4–6 capsules (500 mg) twice daily (40 mg gamolenic acid per capsule).
Route of Administration: Oral
In Vitro Use Guide
Sources: www.ncbi.nlm.nih.gov/pubmed/19356705
The cells were treated with various concentrations of gamolenic acid for 24 h and cell viability was determined by the MTT assay. Treatment of the K562 cells with gamolenic concentrations less than 50 uM did not inhibit cell viability, but treatment with concentrations of 50-150 uM caused a dosedependent decrease, and the concentration of gamolenic acid inducing 50% cell inhibition (IC50) after 24 h was 101.59 uM.
Substance Class Chemical
Created
by admin
on Sun Dec 18 06:47:20 UTC 2022
Edited
by admin
on Sun Dec 18 06:47:20 UTC 2022
Record UNII
L4WFA9KRB5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM .GAMMA.-LINOLENATE
Systematic Name English
6,9,12-OCTADECATRIENOIC ACID, SODIUM SALT (1:1), (6Z,9Z,12Z)-
Systematic Name English
SODIUM GAMMA-LINOLENATE
Systematic Name English
6,9,12-OCTADECATRIENOIC ACID, SODIUM SALT, (6Z,9Z,12Z)-
Systematic Name English
.GAMMA.-LINOLENIC ACID SODIUM SALT
Common Name English
Code System Code Type Description
PUBCHEM
23676161
Created by admin on Sun Dec 18 06:47:20 UTC 2022 , Edited by admin on Sun Dec 18 06:47:20 UTC 2022
PRIMARY
CAS
86761-55-9
Created by admin on Sun Dec 18 06:47:20 UTC 2022 , Edited by admin on Sun Dec 18 06:47:20 UTC 2022
PRIMARY
FDA UNII
L4WFA9KRB5
Created by admin on Sun Dec 18 06:47:20 UTC 2022 , Edited by admin on Sun Dec 18 06:47:20 UTC 2022
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE